Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray …PR Newswire UK (press release)Oncology testing and HLA typing testing are also projected to grow at a rapid rate during the same forecast period. Technology wise, PCR accounts…
Moneycontrol.com |
Big Pharma pushes for US action against India on drugs
Livemint In 2012, India issued its first ever compulsory licence to domestic drug maker Natco Pharma Ltd on a kidney and liver cancer drug, Nexavar, patented by Germany’s Bayer AG, in a move that it had said endangered pharmaceutical research. AstraZeneca Plc … Big Pharma pushes for US action against India over patent worrieseuronews |
|
EDITORIAL: Consider organ donation today to possibly save a life tomorrow
Monitor In the Central and South Texas region — which includes 56 counties from Waco south to the Rio Grande Valley — 436 patients received life-saving organ transplants from 119 deceased donors, Segovia said. This is up from 2012, when 353 people received … Agency sees increase in organ donationsValley morning Star |
|
South Texas organ donation sets new annual record
Monitor HARLINGEN — Organ donation in South and Central Texas increased last year with a record-setting 436 persons receiving transplants from 119 donors, according to the Texas Organ Sharing Alliance. TOSA spokeswoman Edwina Garza said efforts by … |
|
AbbVie Inc. Is Closer to Much-Needed Diversification, but Is It Enough?
DailyFinance Other drugs like Elagolix and daclizumab also address meaningful potential markets, and AbbVie isn’t known for moving low-probability drugs into expensive late-stage tests. Even so, there are “buts” here – the success of Elagolix and daclizumab will … |
Firstpost |
Gilead to license hepatitis C drug to lower-cost manufacturers in India
Firstpost The World Health Organization estimates that about three percent of the world’s population has been infected with the hepatitis C virus and that more than 170 million chronic carriers are at risk of developing liver cirrhosis, liver cancer or both … |
|
AbbVie Inc. Is Closer to Much-Needed Diversification, but Is It Enough?
Motley Fool Other drugs like Elagolix and daclizumab also address meaningful potential markets, and AbbVie isn’t known for moving low-probability drugs into expensive late-stage tests. Even so, there are “buts” here – the success of Elagolix and daclizumab will … |
|
King George’s Medical University, PGI doctors perform dual organ transplant
Times of India Thereafter, organs were prepared and preserved for transplant and transferred to Sanjay Gandhi Post Graduate Institute of Medical sciences for transplant surgery. Here, a huge surgical team comprising doctors from both SGPGI and KGMU began two … |
|
Researchers identify key step to prevent liver failure resulting from …
News-Medical.net “Overdose of paracetamol is the most common cause of acute liver failure and the leading cause of liver damage requiring transplantation in developed countries. The precise mechanisms of liver toxicity due to paracetamol overdose, however, have … |
CAR T-Cell Therapies: Positive Early ResultsClinical Oncology NewsThe feasibility of CAR therapy in patients with advanced disease and multiple previous therapies, including hematopoietic stem cell transplant (HSCT), was underscored in a series of 10 p…